Level Brands Closes Acquisition of cbdMD

The company has closed its acquisition of Cure Based Development, LLC, the owner of the nationally recognized consumer products brand cbdMD, in an all-stock transaction.

HARLOTTE, N.C.--(BUSINESS WIRE)--PRESS RELEASE--Level Brands, Inc. has announced that it has closed its acquisition of Cure Based Development, LLC, the owner of the nationally recognized consumer brand cbdMD, in an all-stock transaction. cbdMD is a consumer products brand offering a large selection of cbdMD branded CBD products primarily through its ecommerce website, www.cbdMD.com, as well as through 700 current third party retail locations. cbdMD manufactures its line of products at its Charlotte, NC facility using 100 percent, all-natural CBD extracted from organic, non-GMO, vegan and gluten-free industrial hemp grown in the USA.

In consideration of the purchase price, Level Brands will issue 15,250,000 shares of its common stock and it may issue up to an additional 15,250,000 shares during the first 60 months if revenue milestones aggregating $300 million are achieved. The revenue milestones are targeted at $20 million in the first 12 months, $40 million in the next 12 months, $80 million in the next 18 months and $160 million in the final 18 months.

“With the acquisition of cbdMD, I believe Level Brands now becomes one of the leading CBD consumer companies in America. The cbdMD brand has shown consistent month-over-month double-digit growth rates and, with the capital we have available, we believe we can significantly accelerate the revenue growth and execute on an aggressive expansion and brand positioning plan which should yield continued significant growth rates. Now that the Farm Bill has been approved, and CBD will no longer be listed as a Schedule 1 controlled substance, we believe the CBD market should drastically expand. CBD products will now have access to retailers nationwide, as well as through online channels. In addition, the passage of this legislation should help CBD gain mainstream consumer acceptance. We believe cbdMD will significantly gain market share in this growing industry,” said Martin Sumichrast, chairman and CEO of Level Brands.

“I was first introduced to CBD as a consumer and it really worked for me. Since launching the company, our goal has been to bring a unique product to our loyal customers with the goal of enhancing their overall quality of life and providing education and awareness to the potential benefits of CBD. In the process, we expect to build cbdMD into the leading CBD brand. We have built a reputation as a premier manufacturer of high-quality products at a very affordable price, giving our customers a great value. Now with the passage of the Farm Bill, we expect not only that our business will expand as major retail chains start to carry CBD, but also this mass retail acceptance will encourage a larger customer base who will want to try our products. In addition, our access to athletes and the sporting world should enhance the marketability of our products,” said Scott Coffman, the founder and CEO of cbdMD.

cbdMD’s founder is Scott Coffman, the founder of Blu-Ecig. Mr. Coffman started Blu and sold it to Lorillard Tobacco for $135 million. Mr. Coffman, who will join Level Brands’ Board and will continue as CEO of cbdMD, will be a significant shareholder of Level Brands.

“While our products are currently in over 700 retail outlets in the U.S. and we are gearing up to expand our retail footprint, we also believe in growing our e-commerce channel. We believe we will separate ourselves from our competitors through our unique online marketing campaigns. Since CBD is generally recognized as being most effective when you take it regularly, our online re-order programs provide an easy, cost effective way to get our products to our customers,” said Caryn Dunayer, president of cbdMD.

Historic information on cbdMD’s products can be found in the presentations furnished in a Current Report on Form 8-K as filed by Level Brands on Dec. 21, 2018.